Deciphera Pharmaceuticals, Inc. (DCPH)
|52 Week Range||12.41-22.76|
|1y Target Est||-|
|DCF Unlevered||DCPH DCF ->|
|DCF Levered||DCPH LDCF ->|
|Debt / Equity||6.81%||Neutral|
Upgrades & Downgrades
Latest DCPH news
Deciphera Pharmaceuticals: Clawing Its Way Back
22 August 2023
Deciphera Pharmaceuticals is focused on the development of their multikinase inhibitor ripretinib for the treatment of gastrointestinal stromal tumor. The INSIGHT study is comparing ripretinib against...
Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now
21 August 2023
Biotech stocks may offer some of the most explosive opportunities on the market. For one, we have millions of baby boomers demanding better care.
3 Under-the-Radar Biotech Stocks to Buy in 2023
19 August 2023
Deciphera Pharmaceuticals' lead therapy is Qinlock, to treat gastrointestinal stromal tumors. Mirati Therapeutics' Krazati is showing promise as a part of a combination therapy.
Why Shares of Deciphera Pharmaceuticals Rose This Week
11 August 2023
Deciphera saw revenue rise by 17.4% year over year. The company's only marketed therapy is Qinlock to treat advanced GIST.
Deciphera (DCPH) Q2 Earnings Beat, Qinlock Drives Revenues
10 August 2023
Deciphera (DCPH) reports narrower-than-expected loss for the second quarter of 2023. Qinlock drives year-over-year sales.
Deciphera Is A Buy In Expectation Of A Significant Comeback
18 June 2023
After a period of bad news, DCPH has slowly inched back into a positive period. They have a lot of good news and some upcoming catalysts. Current prices make it quite attractive.
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 3.6% Since Last Earnings Report?
2 June 2023
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock?
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
8 May 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve ...
Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2023 Earnings Call Transcript
7 May 2023
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Jen Larson - Senior Vice President-Finance and Investor Relations Steve Hoer...